Ahmedabad, India

Mayur Patel

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Intas Pharmaceuticals Limited. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mayur Patel. Retrieved from https://idiyas.com/inventor/mayur-patel-zh7rcqei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mayur Patel: Innovator in Pharmaceutical Composition

Introduction

Mayur Patel is a notable inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance content uniformity.

Latest Patents

One of Mayur Patel's key inventions is a pharmaceutical composition that includes cyclophosphamide. This invention focuses on formulations that comprise cyclophosphamide alone or in combination with other active ingredients and excipients. Notably, the cyclophosphamide in this composition has a D90 particle size of less than 100 microns, which is crucial for improving the effectiveness of the drug.

Career Highlights

Mayur Patel is currently associated with Intas Pharmaceuticals Limited, a prominent player in the pharmaceutical industry. His work at Intas has allowed him to focus on innovative solutions that address various medical needs.

Collaborations

Throughout his career, Mayur has collaborated with talented individuals such as Priyank Patel and Mahendra Patel. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Mayur Patel's contributions to pharmaceutical compositions demonstrate his commitment to innovation in the healthcare sector. His work continues to impact the industry positively, paving the way for advancements in drug formulation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…